Fargier-Bochaton, Odile
Wang, Xinzhuo
Dipasquale, Giovanna
Laouiti, Mohamed
Kountouri, Melpomeni
Gorobets, Olena
Nguyen, Nam P.
Miralbell, Raymond
Vinh-Hung, Vincent
Article History
Received: 11 May 2021
Accepted: 24 November 2021
First Online: 11 January 2022
Competing interests
: N.P.N. and V.V.H. have joint patents for the application of the mean absolute dose deviation, USPTO 62/608,751, WO/2019/014384. G.D. and Geneva University Hospitals have a patent pending for a prone immobilization device, EP18 206 344.6, 52146/WO. R.M. had research grants from BrainLab and from Varian AG. V.V.H. had contact with Varian Medical Systems in 2012–2013 for the installation of Varian Pivotal Prone Breast Care at the Radiation Oncology department of the Geneva University Hospitals, Switzerland. The Radiation Oncology Department of the Geneva University Hospitals had a research agreement with Varian Medical Systems. The department received research funding from the Fundació Privada CELLEX. The other authors declare no competing interests.